[{"Assets_0_Q2_USD":70940000.0,"CommonStockSharesOutstanding_0_Q2_shares":13120000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":3929000.0,"NetIncomeLoss_1_Q2_USD":-685000.0,"NetIncomeLoss_2_Q2_USD":-7569000.0,"StockholdersEquity_0_Q2_USD":21618000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190814"}]